Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $74.2700 (-13%) ($73.5800 - $82.1800) on Mon. Mar. 16, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.88% (three month average) | RSI | 36 | Latest Price | $74.2700(-13%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -2.6% a day on average for past five trading days. | Weekly Trend | ABBV declines -3.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(52%) DIA(51%) IVE(50%) | Factors Impacting ABBV price | ABBV will decline at least -1.44% in a week (0% probabilities). VIXM(-36%) VXX(-13%) TLT(-13%) UUP(-1%) IGOV(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.44% (StdDev 2.88%) | Hourly BBV | -2 () | Intraday Trend | -5.8% | | | |
|
Inflection Point | Yes | Resistance Level | $87.83 | 5 Day Moving Average | $82.13(-9.57%) | 10 Day Moving Average | $85.21(-12.84%) | 20 Day Moving Average | $87.83(-15.44%) | To recent high | -24.1% | To recent low | 0% | Market Cap | $131.033b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |